Trial Profile
Vesicare (solifenacin) in the treatment of urinary incontinence after radical prostatectomy.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Nov 2015
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary)
- Indications Urinary incontinence
- Focus Therapeutic Use
- 12 Jun 2014 Status changed from discontinued to completed to match the status with ClinicalTrials.gov record (NCT01215721).
- 12 Jun 2014 Status changed from discontinued to completed to match the status with ClinicalTrials.gov record (NCT01215721).
- 04 Sep 2013 The extension trial is now completed according to the ClinicalTrials.gov record.